FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1586805860> ?p ?o ?g. }

• W1586805860 endingPage "16724" @default.
• W1586805860 startingPage "16712" @default.
• W1586805860 abstract "Enhancer of Zeste Homolog 2 (EZH2) plays an essential epigenetic role in Diffuse Large B Cell Lymphoma (DLBCL) development. Recurrent somatic heterozygous gain-of-function mutations of EZH2 have been identified in DLBCL, most notably affecting tyrosine 641 (Y641), inducing hyper-trimethylation of H3K27 (H3K27me3). Novel EZH2 inhibitors are being tested in phase 1 and 2 clinical trials but no study has examined which patients would most benefit from this treatment. We evaluated the immunohistochemical (IHC) methylation profiles of 82 patients with DLBCL, as well as the mutational profiles of 32 patients with DLBCL using NGS analysis of a panel of 34 genes involved in lymphomagenesis. A novel IHC score based on H3K27me2 and H3K27me3 expression was developed, capable of distinguishing patients with wild-type (WT) EZH2 and patients with EZH2 Y641 mutations (p = 10-5). NGS analysis revealed a subclonal EZH2 mutation pattern in EZH2 mutant patients with WT-like IHC methylation profiles, while associated mutations capable of upregulating EZH2 were detected in WT EZH2 patients with mutant-like IHC methylation profiles. IHC and mutational profiles highlight in vivo hyper-H3K27me3 and hypo-H3K27me2 status, pinpoint associated activating mutations and determine EZH2 mutation clonality, maximizing EZH2 inhibitor potential by identifying patients most likely to benefit from treatment." @default.
• W1586805860 created "2016-06-24" @default.
• W1586805860 creator A5003078312 @default.
• W1586805860 creator A5007838655 @default.
• W1586805860 creator A5009996302 @default.
• W1586805860 creator A5013080078 @default.
• W1586805860 creator A5018468966 @default.
• W1586805860 creator A5034053189 @default.
• W1586805860 creator A5037806784 @default.
• W1586805860 creator A5039451592 @default.
• W1586805860 creator A5041127210 @default.
• W1586805860 creator A5044708254 @default.
• W1586805860 creator A5049252531 @default.
• W1586805860 creator A5057563040 @default.
• W1586805860 creator A5066392804 @default.
• W1586805860 creator A5068062811 @default.
• W1586805860 creator A5071739469 @default.
• W1586805860 creator A5082700087 @default.
• W1586805860 date "2015-02-05" @default.
• W1586805860 modified "2023-10-16" @default.
• W1586805860 title "Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: Implications for targeted EZH2 inhibitor therapy?" @default.
• W1586805860 cites W1510576016 @default.
• W1586805860 cites W1971313898 @default.
• W1586805860 cites W1971659434 @default.
• W1586805860 cites W1973628185 @default.
• W1586805860 cites W1977261138 @default.
• W1586805860 cites W1980740976 @default.
• W1586805860 cites W1984068087 @default.
• W1586805860 cites W1987759895 @default.
• W1586805860 cites W1989069691 @default.
• W1586805860 cites W1992915563 @default.
• W1586805860 cites W1999505686 @default.
• W1586805860 cites W2001663034 @default.
• W1586805860 cites W2004380688 @default.
• W1586805860 cites W2006709900 @default.
• W1586805860 cites W2010711123 @default.
• W1586805860 cites W2022866101 @default.
• W1586805860 cites W2024373518 @default.
• W1586805860 cites W2025623420 @default.
• W1586805860 cites W2034203447 @default.
• W1586805860 cites W2042093631 @default.
• W1586805860 cites W2053421436 @default.
• W1586805860 cites W2058574523 @default.
• W1586805860 cites W2060608189 @default.
• W1586805860 cites W2061846271 @default.
• W1586805860 cites W2081993205 @default.
• W1586805860 cites W2083255319 @default.
• W1586805860 cites W2084295010 @default.
• W1586805860 cites W2100630390 @default.
• W1586805860 cites W2116318886 @default.
• W1586805860 cites W2118203903 @default.
• W1586805860 cites W2139954541 @default.
• W1586805860 cites W2147246240 @default.
• W1586805860 cites W2149077367 @default.
• W1586805860 cites W2158102062 @default.
• W1586805860 cites W2169446357 @default.
• W1586805860 cites W2320983896 @default.
• W1586805860 cites W2397677784 @default.
• W1586805860 doi "https://doi.org/10.18632/oncotarget.3154" @default.
• W1586805860 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4599301" @default.
• W1586805860 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25762637" @default.
• W1586805860 hasPublicationYear "2015" @default.
• W1586805860 type Work @default.
• W1586805860 sameAs 1586805860 @default.
• W1586805860 citedByCount "29" @default.
• W1586805860 countsByYear W15868058602015 @default.
• W1586805860 countsByYear W15868058602016 @default.
• W1586805860 countsByYear W15868058602017 @default.
• W1586805860 countsByYear W15868058602018 @default.
• W1586805860 countsByYear W15868058602019 @default.
• W1586805860 countsByYear W15868058602021 @default.
• W1586805860 countsByYear W15868058602022 @default.
• W1586805860 crossrefType "journal-article" @default.
• W1586805860 hasAuthorship W1586805860A5003078312 @default.
• W1586805860 hasAuthorship W1586805860A5007838655 @default.
• W1586805860 hasAuthorship W1586805860A5009996302 @default.
• W1586805860 hasAuthorship W1586805860A5013080078 @default.
• W1586805860 hasAuthorship W1586805860A5018468966 @default.
• W1586805860 hasAuthorship W1586805860A5034053189 @default.
• W1586805860 hasAuthorship W1586805860A5037806784 @default.
• W1586805860 hasAuthorship W1586805860A5039451592 @default.
• W1586805860 hasAuthorship W1586805860A5041127210 @default.
• W1586805860 hasAuthorship W1586805860A5044708254 @default.
• W1586805860 hasAuthorship W1586805860A5049252531 @default.
• W1586805860 hasAuthorship W1586805860A5057563040 @default.
• W1586805860 hasAuthorship W1586805860A5066392804 @default.
• W1586805860 hasAuthorship W1586805860A5068062811 @default.
• W1586805860 hasAuthorship W1586805860A5071739469 @default.
• W1586805860 hasAuthorship W1586805860A5082700087 @default.
• W1586805860 hasBestOaLocation W15868058601 @default.
• W1586805860 hasConcept C104317684 @default.
• W1586805860 hasConcept C203014093 @default.
• W1586805860 hasConcept C204232928 @default.
• W1586805860 hasConcept C2778559949 @default.
• W1586805860 hasConcept C2779338263 @default.
• W1586805860 hasConcept C33288867 @default.
• W1586805860 hasConcept C41091548 @default.
• W1586805860 hasConcept C50171091 @default.

• next